You can see all the details in their Annual Report. The reality is that Perry has largely been paid in performance incentives, and so it is technically correct that he would need to sell some as they vest to pay taxes if he doesn't have alternative income streams. Problem with this is
1) performance fees are ridiculously high - to the point where the performance rights over the past 3 years were greater than the total revenue of the company in FY21.
2) a temporary CFO of <18 months got over $6m in pay including performance rights - during this period, the performance rights were pretty impressive for all of management
3) KPIs are way too easy to achieve and short term focused - they simply don't align with the interests of shareholders.
4) total management and director's fees relative to the size of the company is out of kilter - the company has paid ~$40m over 3 years ($13m+ p/a) for essentially four senior management positions (CEO, CFO, COO, CTO), while being a small cap.
To put some of that in comparison, MVP paid $1.6m in executive management team (3 people) and a further $280k for directors - they're also a small cap medical device company on the ASX, so one should think relatively comparable. Or Sonic Health, with +$500m profit on $6.8bn of revenues in FY20, paid management (3 people) $7.5m and director's $1.3m (sorry didn't have on hand the FY21 report). Anyway, you can see that Avita has a serious problem here, and until the board is rolled and the CEO is booted, I struggle to see how this changes.
- Forums
- ASX - By Stock
- Ann: Change of Director's Interest Notice - Michael Perry
You can see all the details in their Annual Report. The reality...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.98 |
Change
-0.040(1.32%) |
Mkt cap ! $213.6M |
Open | High | Low | Value | Volume |
$3.03 | $3.03 | $2.97 | $85.94K | 28.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45 | $2.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.99 | 280 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45 | 2.980 |
4 | 2612 | 2.970 |
3 | 13056 | 2.960 |
6 | 5588 | 2.950 |
2 | 3250 | 2.940 |
Price($) | Vol. | No. |
---|---|---|
2.990 | 280 | 1 |
3.010 | 1829 | 1 |
3.020 | 6599 | 2 |
3.030 | 4280 | 4 |
3.040 | 4279 | 3 |
Last trade - 12.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online